Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism

Danish Medical Bulletin

Volumn 46, Issue 1, 1999, Pages 13-34

  Vestergaard, Henrik ^a,b  

^a STENO DIABETES CENTER   (Denmark)

^b Steno Diabetic Center ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; GLUCOSE; GLYCOGEN SYNTHASE; HEXOKINASE; INSULIN;

ARTICLE; ENZYME ACTIVITY; ENZYME INDUCTION; GENE EXPRESSION REGULATION; GLUCOSE METABOLISM; HORMONAL REGULATION; HUMAN; MUSCLE METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS;

ANIMALS; GENE EXPRESSION REGULATION; GLUCOSE; GLYCOGEN SYNTHASE; HEXOKINASE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MUSCLE, SKELETAL; PHOSPHOFRUCTOKINASE-1;

EID: 0032993608     PISSN: 09078916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (321)

1. Andersen, O., Falholt, K., & Kühl, C. (1989). Activity of enzymes of glucose and triglyceride metabolism in adipose and muscle tissue from normal pregnant women at term. Diabetic Medicine, 6, 131-136.
2. Andres, R., Swerdloff, R., Pozefsky, T. & Coleman, D. (1966). Manual feedback technique for the control of blood glucose concentration. New York: Mediad Inc.
3. 2- and COOH-terminal halves.Journal of Biological Chemistry, 271, 1849-1852.
4. Arora, K.K., Filburn, C.R., & Pedresen, P.L. (1993). Structure/function relationships in hexokinase. Journal of Biological Chemistry, 268, 18259-18266.
5. Attvall, S., Fowelin, J., Lager, I., Von Schenck, H., & Smith, U. (1993). Smoking induces insulin resistance - a potential link with the insulin resistance syndrome. Journal of Internal Medicine, 233, 327-332.
6. Azpiazu, L, Saltiel, A.R., DePaoli-Roach, A.A., & Lawrence, J.C. (1996). Regulation of both glycogen synthase and PHAS-I by insulin in rat skeletal muscle involves mitogen-activated protein kinase-independent and rapamycin-sensitive pathway. Journal of Biological Chemistry, 271, 5033-5039.
7. Bak, J.F., Jacobsen, U.K., Jørgensen, F.S., & Pedersen, O. (1989a). Insulin receptor function and glycogen synthase activity in skeletal muscle biopsies from patients with insulin-dependent diabetes mellitus: Effects of physical training. J Clin Endocrinol Metab, 69, 158-164.
8. Bak, J.F., Schmitz, O., Schwartz Sørensen, N., & Pedersen, O. (1989b). Postreceptor effects of sulfonylurea on skeletal muscle glycogen synthase activity in type II diabetic patients. Diabetes, 38, 1343-1350.
9. Bak, J.F. & Pedersen, O. (1990). Exercise-enhanced activation of glycogen synthase in human skeletal muscle. Am J Physiol (Endocrinol Metab), 258, E957-E963.
10. Bak, J.F., Møller, N., & Schmilz, O. (1991). Effects of growth hormone on fuel utilization and muscle glycogen synthase activity in normal humans. Am J Physiol (Endocrinol Metab ), 260, E736-E742.
11. Bak, J.F., Møller, N., Schmitz, O., Saaek, A., & Pedersen, O. (1992). In vivo insulin action and muscle glycogen synthase activity in type 2 (non-insulin-dependent) diabetes mellitus: effects of diet treatment. Diabetologia, 35, 777-784.
12. Barker, H.M., Jones, T.A., da Cruz e Silva, E.F., Spurr, N.K., & Cohen, P.T.W. (1990). Localization of the encoding a type 1 protein phosphatase catalytic subunit to human chromosome band 11q13. Genomics, 7, 159-166.
13. Barker, H.M., Craig, S.P., Spurr, N.K., & Cohen, P.T.W. (1993). Sequence of protein/threonine phosphatase 1 gamma and localization of the gene (PP1CC) encoding it to chromosome bands 12q24. 1-q24.2. Biochimica et Biophysica Acta, 1178, 228-233.
14. Barker, H.M., Brewis, N.D., Street, A.J., Spurr, N.K., & Cohen, P.T.W. (1994). Three genes for protein phosphatase 1 map to different human chromosomes: sequence, expression and gene localisation of protein/threonine phosphatase beta (PPP1CB). Biochimica et Biophysica Acta, 1220, 212-218.
15. Baron, A.D., Zhu, J., Zhu, J., Weldon, H., Maianu, L., & Garvey, W.T. (1995). Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Journal of Clinical Investigation, 96, 2792-2801.
16. Barriocanal, L.A., Borthwick, A.C., Stewart, M., Wells, A., Hurel, S.J., Yeaman, S.J., & Taylor, R. (1995). The effect of acute (60 minute) insulin stimulation upon human skeletal muscle glycogen synthase and protein phosphatase-1 in non-insulin-dependent diabetic patients and control subjects. Diabetic Medicine, 12, 1110-1115.
17. Bauer, B.A. & Younathan, E.S. (1984). Decreased phosphofructokinase activity in skeletal muscle of diabetic rats. Clin Physiol Biochem, 2, 137-145.
18. Beard, J.C., Bergman, R.N., Ward, W.K., & Porte, D. (1986). The insulin sensitivity index in nondiabetic man. Correlation between clamp-derived and IVGTT-derived values. Diabetes, 35, 362-369.
19. Beck-Nielsen, H., Richelsen, B., Hother-Nielsen, O., Heding, L.G., & Schwartz Srrensen, N. (1984). Improved in vivo insulin effect during continuous subcutaneous insulin infusion in patients with IDDM. Diabetes, 33, 832-837.
20. Beck-Nielsen, H. & Groop, L. (1994). Metabolic and genetic characterization of prediabetic ststaes. Sequence events leading to non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation, 94, 1714-1721.
21. Becker-André, M. & Hahlbrock, K. (1989). Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Research, 17, 9437-9446.
22. Beitner, R., Cohen, T.J., Nordenberg, J., & Haberman, S. (1979). Glucose 1,6-bisphosphate and the mechanism of the pasteur effect in diaphragm muscle. The regulation of hexokinase and phosphofructokinase activities. Biochimica et Biophysica Acta, 586, 266-277.
23. Bergman, R.N., Finegood, D.T., & Ader, M. (1985). Assessment of insulin sensitivity in vivo. Endocrine Reviews, 6, 45-86.
24. Bergman, R.N. (1989). Toward physiological understanding of glucose tolerance Minimal-model approach. Diabetes, 38, 1512-1527.
25. Bergmeyer, H.U., Grassl, M. & Walter, H. (1983). Enzymes. In H.U. Bergmeyer, J. Bergmeyer & M. Grassl (Eds.). Methods of enzymatic analysis. Volume II. Samples, reagents, assessment of results (3rd ed.) (pp. 185-186). Verlag Chemie: Weinheim, Deerfield Beach Florida, Basel.
26. Bernstein, R.S. & Kipnis, D.M. (1973). Regulation of rat hexokinase isoenzymes. I. assay and effect of age, fasting and refeeding. Diabetes, 22, 913-922.
27. Bessman, S.P. (1972). Hexokinase acceptor theory of insulin action. Israel Journal of Medical Sciences, 8, 344-352.
28. Beutler, E. (1971). Phosphofructokinase. Red Cell Metabolism: A Manual of Biochemical Methods Edit: E Beutler Grune & Stratton, Inc. New York, 42-44.
29. Bjørbæk, C., Echwald, S., Hubricht, P., Vestergaard, H., Hansen, T., Zierath, J., & Pedersen, O. (1994). Genetic variants in promotors and coding regions of the muscle glycogen synthase and the insulin-responsive GLUT4 genes in NIDDM. Diabetes, 43, 976-983.
30. Bjørbæk, C., Vik, T.A., Echwald, S., Yang, P.-Y., Vestergaard, H., Wang, J.P., Webb, G.C., Richmond, K., Hansen, T., Erikson, R.L., Miklos, G.L.G., Cohen, P.T.W., & Pedersen, O. (1995). Cloning of a human insulin-stimulated protein kinase (ISPK-1) gene and analysis of coding regions and mRNA leveles of the ISPK-1 and the protein phosphatase-1 genes in muscle from NIDDM patients. Diabetes, 44, 90-97.
31. Blomstrand, E., Ekblom, B., & Newsholme, E.A. (1986). Maximum activities of key glycolytic and oxidative enzymes in human muscle from differently trained individuals. J Physiol, 381, 111-118.
32. Boden, G., Jadali, F., White, J., Liang, Y., Mozzoli, M., Chen, X., Coleman, E., & Smith, C. (1991). Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. Journal of Clinical Investigation, 88, 960-966.
33. Boden, G., Chen, X., White, J.V., & Rossetti, L. (1994). Mechanisms of fatty acid-induced inhibition of glucose uptake. JCI, 93, 2438-2446.
34. Bogardus, C., Ravussin, E., Robbins, D.C., Wolfe, R.R., Horton, E.S., & Sims, E.A.H. (1984). Effects of physical training and diet therapy on carbohydrate metabolism in petients with glucose intolerance and non-insulin-dependent diabetes mellitus. Diabetes, 33, 311-318.
35. Bonadonna, R.C., Zyck, K., Boni, C., Ferrannini, E., & DeFronzo, R.A. (1989). Time dependence of the interaction between lipid and glucose in humans. Am J Physiol (Endocrinol Metab ), 257, E49-E56.
36. Boscá, E., Aragón, J.J., & Sols, A. (1985). Modulation of muscle phosphofructokinase at physiological concentration of enzyme. Journal of Biological Chemistry, 260, 2100-2107.
37. Braithwaite, S.S., Palazuk, B., Colca, J.R., Edwards III, C.W., & Hofmann, C. (1995). Reduced expression of hexokinase II in insulin-resistant diabetes. Diabetes, 44, 43-48.
38. Browner, M.F., Nakano, K., Bang, A.G., & Fletterick, R.J. (1989). Human muscle glycogen synthase cDNA sequence: A negatively charged protein with an asymmetric charge distribution. Proc Natl Acad Sci USA, 86, 1443-1447.
39. Burcelin, R., Printz, R.L., Kande, J., Assan, R., Granner, D.K., & Girard, J. (1993). Regulation of glucose transporter and hexokinase II expression in tissues of diabetic rats. Am J Physiol (Endocrinol Metab ), 265, E392-E401.
40. Bøtker, H.E., Møller, N., Ovesen, P., Mengel, A., Schmitz, O., Ørskov, H., & Bagger, J.P. (1993). Insulin resistance in microvascular angina (syndrome X). Lancet, 342, 136-140.
41. Cai, G-Z., Lee, L.L.-Y, Luther, M.A., & Lee, J.C. (1990). Regulation and quarternary structural changes in rabbit skeletal muscle phosphofructokinase. Biophysical Chemistry, 37, 97-106.
42. Calder, P.C. (1991). Glycogen structure and biogenesis.Int J Biochem, 23, 1335-1352.
43. Campbell, D.G. & Cohen, P. (1989). The amino acid sequence of rabbit skeletal muscle glycogenin. European Journal of Biochemistry, 185, 119-125.
44. Castillo, C.E., Katz, A., Spencer, M.K., Yan, Z., & Nyomba, B.L. (1991). Fasting inhibits insulin-mediated glycolysis and anaplerosis in human skeletal muscle. Am J Physiol (Endocrinol Metab ), 261, E598-E605.
45. Chang, P., Jensen, J., Printz, R.L., Granner, D.K., Ivy, J.L., & Moller, D.E. (1996). Overexpression of hexokinase 11 in transgenic mice. Journal of Biological Chemistry, 271, 14834-14839.
46. Cheatham, B. & Kahn, C.R. (1995). Insulin action and the insulin signaling network.Endocrine Reviews, 16, 117-142.
47. Chen, Y.H., Hansen, L., Chen, M.X., Bjørbæk, C., Vestergaard, H., Hansen, T., Cohen, P.T.W., & Pedersen, O. (1994). Sequence of the human glycogen-associated regulatory subunit if type 1 protein phosphatase and analysis of its coding region and mRNA level in muscle from patients with NIDDM. Diabetes, 43, 1234-1241.
48. Chen-Zion, M., Livnat, T., & Beitner, R. (1992). Insulin rapidly stimulates binding of phosphofructokinase and aldolase to muscle skeleton. International Journal of Biochemistry, 24, 821-826.
49. Chi, M.M.-Y, Hintz, C.S., Coyle, E.F., Martin III, W.H., Ivy, J.L., Nemeth, P.M., Holloszy, J.O., & Lowry, O.H. (1983). Effects of detraining on enzymes of energy metabolism in individual human muscle fibers. Am J Physiol (Cell Physiol ), 244, C276-C287.
50. Christiansen, E., Vestergaard, H., Tibell, A., Hother-Nielsen, O., Holst, J.J., Pedersen, O., & Madsbad, S. (1996). Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Diabetes, 45, 1267-1275.
51. Clarke, F., Stephan, P., Morton, D. & Weidemann, J. (1985). R. Beitner (Ed.). Regulation of carbohydrate metabolism (pp. 1-31). Boca Raton, FL: CRC Press.
52. Clarke, F.M. & Masters, C.J. (1975). On the association of glycolytic enzymes with structural proteins of skeletal muscle. Biochimica et Biophysica Acta, 381, 37-46.
53. Clausen, J.O., Borch-Johnsen, K., Ibsen, H., Bergman, R.N., Hougaard, P., Winther, K., & Pedersen, O. (1996). Insulin sensitivity index, acute insulin response, and glucose effectivenss in a population-based sample of 380 young healthy Caucasians. Journal of Clinical Investigation, 98, 1195-1209.
54. Cohen, P. (1986). Muscle glycogen synthase. In P.D. Boyer & E.G. Krebs (Eds.). The enzymes (3rd ed.) (pp. 461-497). Harcourt Brace Jovanovich, Publishers: Orlando, San Diego, New York, Austin, Boston, London, Sydney, Tokyo, Toronto.
55. Cohen, P. (1989). The structure and regulation of protein phosphatases. Ann Rev Biochem, 58, 433-508.
56. Crook, E.D., Daniels, M.C., Smith, T.M., & McClain, D.A. (1993). Regulation of insulin-stimulated glycogen synthase activity by overexpression of glutamine: fructose-6-phosphate amidotransferase in rat-1 fibroblasts. Diabetes, 42, 1289-1296.
57. Crook, E.D., Zhou, J., Daniels, M., Neidigh, J.L., & McClain, D.A. (1995). Regulation of glycogen synthase by glucose, glucosamine, and glutamine: fructose-6-phosphate amidotransferase. Diabetes, 44, 314-320.
58. Crook, E.D. & McClain, D.A. (1996). Regulation of glycogen synthase and protein phosphatase-1 by hexosamines. Diabetes, 45, 322-327.
59. Cross, D.A., Alessi, D.R., Vandenheede, J.R., McDowell, H.E., Hundal, H.S., & Cohen, P. (1994). The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal msucel cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem J, 303, 21-26.
60. Cross, D.A.E., Alessi, D.R., Cohen, P., Andjelkovich, M., & Hemmings, B.A. (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature, 378, 785-789.
61. Damm, P., Vestergaard, H., Kühl, C., & Pedersen, O. (1996). Impaired insulin-stimulated nonoxidative glucose-metabolism in glucose-tolerant women with prvious gestational diabetes. American Journal of Obstetrics and Gynecology, 174, 722-729.
62. Damsbo, P., Vaag, A., Hother-Nielsen, O., & Beck-Nielsen, H. (1991). Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia, 34, 239-245.
63. Daniele, A., Altruda, F., Ferrone, M., Silengo, L., Romeo, G, Archidiacone, N., & Rocchi, M. (1992). Mapping of the human hexokinase I gene to 10q11->gter. Human Hered, 42, 107-110.
64. De Meyts, P., Christoffersen, C.T., Tornquist, H., & Seedorf, K. (1996). Insulin recpetors and insulin action. Current Opinion in Endocrinology and Diabetes, 3, 369-377.
65. Deeb, S.S., Malkki, M., & Laakso, M. (1993). Human hexokinase II: sequence and homology to other hexokinases. Biochemical and Biophysical Research Communications, 197, 68-74.
66. DeFronzo, R.A. (1979). Glucose intolerance and aging. Evidence for tissue insensitivity to insulin. Diabetes, 28, 1095-1101.
67. DeFronzo, R.A., Hendler, R., & Simonson, D. (1982). Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes, 31, 795-801.
68. DeFronzo, R.A., Sherwin, R., & Kraemer, N. (1987). Effect of physical training on insulin action in obesity. Diabetes, 36, 1379-1385.
69. DeFronzo, R.A. & Ferrannini, E. (1991). Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care, 14, 173-194.
70. DeFronzo, R.A., Bonadonna, R., & Ferrannini, E. (1992). Pathogenesis of NIDDM. A balanced overview. Diabetes Care, 15, 318-368.
71. Del Prato, S., Nosadini, R., Tiengo, A., Tessari, P., Avogaro, A., Trevisan, R., Valerio, A., Muggeo, M., Cobelli, C., & Toffolo, G. (1983). Insulin-mediated glucose diposal in type 1 diabetes: evidence for insulin resistance.J Clin Endocrinol Metab, 57, 904-910.
72. Dela, F., Ploug, T., Handberg, A., Petersen, L.N., Mikines, K.J., & Galbo, H. (1994). Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM. Diabetes, 43, 862-865.
73. Dela, F., Larsen, J.J., Mikines, K.J., Ploug, T., Nørgaard Petersen, L., & Galbo. H. (1995). Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training.Diabetes, 44, 1010-1020.
74. Dent, P., Lavoinne, A., Nakielny, S., Caudwell, F.B., Watt, P., & Cohen, P. (1990). The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle. Nature, 348, 302-308.
75. DePaoli-Roach, A.A., Ahmad, Z., Camici, M., Lawrence, J.C., & Roach, P.J. (1983). Multiple phosphorylation of rabbit skeletal muscle glycogen synthase. Journal of Biological Chemistry, 258, 10702-10709.
76. Easterby, J.S. & O'Brien, M.J. (1973). Purification and properties of pig-heart hexokinase.European Journal of Biochemistry, 38, 201-211.
77. Easterby, J.S. & Qadri, S.S. (1977). Hexokinase type II from rat skeletal muscle. Methods in Enzymology, 90, 11-15.
78. Easterby, J.S. & Qadri, S.S. (1981). Effects of metabolites on the activity of mammalian hexokinases. Biochemical Society Transactions, 9, 25-27.
79. Eastman, R.C., Carson, R.E., Gordon, M.R., Berg, G.W., Lillioja, S., Larson, S.M., & Roth, J. (1990). Brain glucose metabolism in noninsulin-dependent diabetes mellitus: A study in Pima Indians using positron emission tomography during hyperinsulinemia with euglycemic glucose clamp. J Clin Endocrinol Metab, 71, 1602-1610.
80. Echwald, S., Bjørbæk, C., Hansen, T., Clausen, J., Vestergaard, H., Zierath, J., Printz, R.L., Granner, D.K., & Pedersen, O. (1995). Identification of four amino substitutions in hexokinase II and studies of relationships to NIDDM, glucose effectiveness, and insulin sensitivity. Diabetes, 44, 347-353.
81. Edelman, S.V., Laakso, M., Wallace, P., Brechtel, G., Olefsky, J.M., & Baron, A.D. (1990). Kinetics of insulin-mediated and non-insulin-mediated glucose uptake in humans. Diabetes, 39, 955-964.
82. Elbein, S.C., Chiu, K.C., Hoffman, M.D., Mayorga, R.A., Bragg, K.L., & Leppert, M.F. (1995). Linkage analysis of 19 candidate regions for insulin resistance in familial NIDDM. Diabetes, 44, 1259-1265.
83. Eriksson, B.O., Gollnick, P.D., & Saltin, B. (1972). Muscle metabolism and enzyme activities after training in boys 11-13 years old. Acta Physiol Scand, 87, 485-497.
84. Eriksson, J., Franssila-Kullunki, A., Ekstrand, A., Salorante, C., WidJn, E., Schalin, C., & Groop, L. (1989). Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med, 321, 337-343.
85. Eriksson, J., Koranyi, L.I., Bourey, R.E., Schalin-Jäntti, C., WidJn, E., Mueckler, M., Permutt, M.A., & Groop, L. (1992). Insulin resistance in Type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle. Diabetologia, 35, 143-147.
86. Essén-Gustavsson, B. & Henriksson, J. (1984). Enzyme levels in pools of microdissected human muscle fibres of identified type. Adaptive response to exercise. Acta Physiol Scand, 120, 505-515.
87. Evans, D.J., Murray, R., & Kissebach, A.H. (1984). Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal and insulin binding Effects of obesity and body fat topography. Journal of Clinical Investigation, 74, 1515-1525.
88. Falholt, K., Jensen, I., Lindkær Jensen, S., Mortensen, H.B., Vølund, A., Heding, L.G., Nørskov Petersen, P., & Falholt, W. (1988). Carbohydrate and lipid metabolism of skeletal muscle in type 2 diabetic patients. Diabetic Medicine, 5, 27-31.
89. Felber, J.P., Ferrannini, E., Golay, A., Meyer, H.U., Thiebaud, D., Curchod, B., Maeder, E., Jequier, E., & DeFronzo, R.A. (1987). Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes.Diabetes, 36, 1341-1350.
90. Felig, P. & Bergman, M. (1995). The endocrine pancreas: diabetes mellitus. In P. Felig, J.D. Baxter & L.A. Frohman (Eds.). Endocrinology and Metabolism (3rd ed.) (pp. 1107-1250). New York: McGRAW-HILL, INC.
91. Felley, C.P., Felley, E.M., Van Melle, G.D., Frascarolo, P., Jéquier, E., & Felber, J.-P. (1989). Impairment of glucose disposal by infusion of triglycerides in humans: role of glycemia. Am J Physiol (Endocrinol Metab ), 256, E747-E752.
92. Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M.A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987). Insulin resistance in essential hypertension. N Engl J Med, 317, 350-357.
93. Foe, L.G. & Kemp, R.G. (1982). Properties of phospho and dephospho forms of muscle phosphofructokinase. Journal of Biological Chemistry, 257, 6368-6372.
94. Franke, T.F., Kaplan, D.R., & Cantley, L.C. (1997). PI3K: Downstream AK-Tion blocks apoptosis. Cell, 88, 435-437.
95. Garland, P.B., Randle, P.J., & Newsholme, E.A. (1974). Citrate as an intermediary in the inhibition of phosphofructokinase in rat heart muscle by fatty acids, ketone bodies, pyruvate, diabetes and starvation. Nature, 200, 169-170.
96. Garvey, W.T., Olefsky, J.M., Griffin, J., Hamman, R.F., & Kolterman, O.G. (1985). The effect of insulin treatment on insulin secretion and insulin action in type 2 diabetes mellitus. Diabetes, 34, 222-234.
97. Garvey, W.T., Olefsky, J.M., Matthaei, S., & Marshall, S. (1987). Glucose and insulin co-regulate the glucose transport system in primary cultered adipocytes. Journal of Biological Chemistry, 262, 189-197.
98. +2 channel antagonists, and α-adrenergic blockers on glucose and lipid metabolism in NIDDM pateints with hypertension. Diabetes, 44, 665-671.
99. Gollnick, P.D., Armstrong, R.B., Saubert IV, C.W., Piehl, K., & Saltin, B. (1972). Enzyme activity and fiber composition in skeletal muscle of untrained and trained men. J Appl Physiol, 33, 312-319.
100. Gollnick, P.D., Armstrong, R.B., Saltin, B., Saubert IV, C.W., Selmbrowich, W.L., & Shepherd, R.E. (1973). Effect of training on enzyme activity and fiber composition of human skeletal muscle. J Appl Physiol, 34, 107-111.
101. Goncharova, N.Y., Shcherbatykh, L.N., Tsupak, U.I., & Aleksakhina, N.V. (1981). Kinetic behaviour of isoenzymes I and II of rat skeletal muscle hexokinase on binding to mitochondrial membranes. Biochemistry, 46, 525-530.
102. Groop, L., Kankuri, M., Camilla, R.T., Schalin-Jäntti, C., Ekstrand, A., Nikula-Ijäs, P., Widén, E., Kuismanen, E., Eriksson, J., Franssila-Kullunki, A., Saloranta, C., & Koskimies, S. (1993). Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med, 328, 10-14.
103. Grossbard, L. & Schimke, R.T. (1966). Multiple hexokinases of rat tissues. Purification and comparison of soluble forms. Journal of Biological Chemistry, 241, 3546-3560.
104. Hansen, L., Hansen, T., Vestergaard, H., Bjørbæk, C., Echwald, S.M., Clausen, J.O., Chen, Y.H., Chen, M.X., Cohen, P.T.W., & Pedersen, O. (1995). A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphatase-1 is associated with insulin resistance and hypersecretion of insulin. Human Molecular Genetics, 4, 1313-1320.
105. Hansen, R., Pilkis, S.J., & Krahl, M.E. (1967). Properties of adaptive hexokinase isozymes of the rat. Endocrinology, 81, 1397-1404.
106. Hansen, R.J., Pilkis, S.J., & Krahl, M.E. (1970). Effect of insulin on the synthesis in vitro of hexokinase in rat epididymal adipose tissue. Endocrinology, 86, 57-65.
107. Henriksson, J. (1992). Effects of physical training on the metabolism of skeletal muscle. Diabetes Care, 15, 1701-1711.
108. Henry, R.R., Ciaraldi, T.P., Abrams-Carter, L., Mudaliar, S., Park, K.S., & Nikoulina, S.E. (1996a). Glycogen synthase activity is reduced in cultered skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Journal of Clinical Investigation, 98, 1231-1236.
109. Henry, R.R., Ciaraldi, T.P., Mudaliar, S., Abrams, L., & Nikoulina, S.E. (1996b). Acquired defects of glycogen synthase activity in cultured human skeletal muscle cells. Diabetes, 45, 400-407.
110. Heumann, S., Falkenberg, F., & Pfleiderer, G. (1974). Purification and immunological characterization of the human hexokinase isoenzymes I and III (ATP-D-hexose 6-phosphotransferase EC 2.7. 1.1). Biochimica et Biophysica Acta, 334, 328-342.
111. Hollenbeck, C.B. & Reaven, G.M. (1987). Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab, 64, 1169-1173.
112. Hother-Nielsen, O. (1996). Constant tracer infusion technique for assessment of glucose turnover in vivo: current status. In S.M. Marshall, P.D. Home & R.A. Rizza (Eds.). The Diabetes Annual/10 (pp. 301-336). Amsterdam: Elsevier Science
113. Huang, M., Lee, C., Lin, R., & Chen, R. (1997). The exchange between proglycogen and macroglycogen and the metabolic role of the protein-rich glycogen in rat skeletal muscel. Journal of Clinical Investigation, 99, 501-505.
114. G from rabbit skeletal muscle. European Journal of Biochemistry, 186, 711-716.
115. Illg, D. & Pette, D. (1979). Turnover rates of hexokinase 1, phosphofructokinase, pyruvate kinase and creatine kinase in slow-twitch soleus muscle and heart of the rabbit. European Journal of Biochemistry, 97, 267-273.
116. Ingebritsen, T.S., Stewart, A.A., & Cohen, P. (1983). The protein phosphatases involved in cellular regulation Measurement of type-1 and type-2 protein phosphatases in extracts of mammalian tissues; an assesment of their physiological roles. European Journal of Biochemistry, 132, 297-307.
117. Jauch, K.-W., Hartl, W., Guenther, B., Wicklmayr, M., Rett, K., & Dietze, G. (1987). Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin-dependent diabetes mellitus. European Journal of Clinical Investigation, 17, 448-454.
118. Jefferson, L.S. (1980). Role of insulin in the regulation of protein synthesis (Lilly Lecture 1979). Diabetes, 29, 487-496.
119. Jéquier, E. (1996). Methods of measuring energy expenditur and substrate utilization. Diabetes Reviews, 4, 423-432.
120. Johnson, A.B., Argyraki, M., Thow, J.C., Broughton, D., Jones, I.R., & Taylor, R. (1990). Effects of intensive dietary treatment on insulin-stimulated skeletal muscle glycogen synthase activation and insulin secretion in newly presenting type 2 diabetic patients. Diabetic Medicine, 7, 420-428.
121. Johnson, A.B., Argyraki, M., Thow, J.C., Jones, I.R., Broughton, D., Miller, M., & Taylor, R. (1991a). Impaired activation of skeletal muscle glycogen synthase in non-insulin-dependent diabetes mellitus is unrelated to degree of obesity. Metabolism, 40, 252-260.
122. Johnson, A.B., Argyraki, M., Thow, J.C., Jones, I.R., Broughton, D., & Taylor, R. (1991b). The effect of sulphonylurea therapy on skeletal muscle glycogen synthase activity and insulin secretion in newly presenting type 2 (non-insulin-dependent) diabetic patients. Diabetic Medicine, 8, 243-253.
123. Johnson, A.B., Agyraki, M., Thow, J.C., Cooper, B.C., Fulcher, G., & Taylor, R. (1992). Effect of increased fatty acid supply on glucose metabolism and skeletal muscle glycogen synthase activity. Clinical Science, 82, 219-226.
124. Kadowaki, T., Kadowaki, H., & Yazaki, Y. (1993). Polymorphisms of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. Letter to the Editor. N Engl J Med, 328, 1569
125. Kahn, A., Meinhofer, M., Cottreau, D., Lagrange, J., & Dreyfus, J. (1979). Phosphofructokinase (PFK) isoenzymes in man. Human Genetics, 48, 93-108.
126. Kahn, C.R. (1994). Banting Lecture. Insulin action, diabetogenes, and the cause of Type II diabetes. Diabetes, 43, 1066-1084.
127. Kaslow, H.R. & Lesikar, D.D. (1984). Isoenzymes of glycogen synthase. EBS, 172, 294-298.
128. Kaslow, H.R., Lesikar, D.D., Antwi, D., & Tan, A.W.H. (1985). L-type glycogen synthase: tissue distribution and electrophoretic mobility. Journal of Biological Chemistry, 260, 9953-9956.
129. Katz, A. & Lee, A.D. (1988a). G-1,6-P2 in human skeletal muscle after isometric contraction. Am J Physiol, 255, C145-C148.
130. Katz, A., Nyomba, B.L., & Bogardus, C. (1988b). No accumulation of glucose in human skeletal muscle during euglycemic hyperinsulinemia. Am J Physiol (Endocrinol Metab ), 255, E942-E945.
131. 2. J Appl Physiol, 65, 487-489.
132. 2 in human skeletal muscle during euglycemic hyperinsulinemia. Am J Physiol, 260, R113-R119.
133. Katz, A., Raz, I., Spencer, M.K., Rising, R., & Mott, D.M. (1991b). Hyper-glycemia induces accumulation of glucose in human skeletal muscle. Am J Physiol (Regulatory Integrative Comp Physiol), 260, R698-R703.
134. Katz, A., Spencer, M.K., Lillioja, S., Yan, Z., Mott, D.M., Haller, R.G., & Lewis, S.F. (1991c). Basal and insulin-mediated carbohydrate metabolism in human muscle deficient in phosphofructokinase 1. Am J Physiol (Endocrinol Metab ), 261, E473-E478.
135. Katz, A. & Yan, Z. (1993). Phosphofructokinase activity in human skeletal muscle: effects of euglycemic hyperinsulinemia and fasting. Scand J clin Lab Invest, 53, 853-858.
136. Katz, A. & Raz, I. (1994). Hexokinase kinetics in human skeletal muscle after hyperinsulinaemia, hyperglycaemia and hyperepinephinaemia. Acta Physiol Scand, 151, 527-530.
137. Katzen, H.M. & Schimke, R.T. (1965). Multiple forms of hexokinase in the rat: tissue distribution, age dependency, and properties. Proc Natl Acad Sci USA, 54, 1218-1225.
138. Katzen, H.M. (1967). The multiple forms of mammalian hexokinase and their significance to the action of insulin. Advances in Enzyme Regulation, 5, 335-356.
139. Katzen, H.M., Soderman, D.D., & Wiley, C.E. (1970). Multiple forms of hexokinase. Activities associated with subcellular particulate and soluble fractions of normal and streptozotocin diabetic rat tissue. Journal of Biological Chemistry, 245, 4081-4096.
140. Kelley, D.E. & Mandarino, L.J. (1990a). Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus. Journal of Clinical Investigation, 86, 1999-2007.
141. Kelley, D.E., Reilly, J.P., Veneman, T., & Mandarino, L.J. (1990b). Effects of insulin on skeletal muscle glucose storage, oxidation, and glycolysis in humans. Am J Physiol (Endocrinol Metab), 258, E923-E929.
142. Kelley, D.E., Mokan, M., Simoneau, J.-A., & Mandarino, L.J. (1993). Interaction between glucose and free fatty acid metabolism in human skeletal muscle. Journal of Clinical Investigation, 92, 91-98.
143. Kelley, D.E., Mintun, M.A., Watkins, S.C., Simoneau, J.-A., Jadali, F., Frederickson, A., Beattie, J., & Thériault, R. (1996). The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. Journal of Clinical Investigation, 97, 2705-2713.
144. Kennedy, L.D., Kirkman, B.R., Lomako, J., Rodriguez, I.R. & Whelan, W.J. (1985). M.C. Berman, W. Gevers & L. Opie (Eds.). Membranes and muscles. Proceedings of an international symposium, Cape Town, Republic of South Africa (pp. 65-84).
145. Kida, Y., Esposito-Del Puente, A., Bogardus, C., & Mott, D.M. (1990). Insulin resistance is associated with reduced fasting and insulin-stimulated glycogen synthase phosphatase activity in human skeletal muscle. Journal of Clinical Investigation, 85, 476-481.
146. Kida, Y., Nyomba, B.L., Bogardus, C., & Mott, D.M. (1991). Defective insulin response of cyclic adenosine monophosphate-dependent protein kinase in insulin resistant humans. Journal of Clinical Investigation, 87, 673-679.
147. Kida, Y., Raz, I., Maeda, R., Nyomba, B.L., Stone, K., Bogardus, C., Sommercorn, J., & Mott, D.M. (1992). Defective insulin response of phosphorylase phosphatase in insulin-resistant humans. Journal of Clinical Investigation, 89, 610-617.
148. Kochan, R.G., Lamb, D.R., Lutz, S.A., Perrill, C.V., Reinman, E.M., & Schlender, K.K. (1979). Glycogen synthase activation in human skeletal muscle: effects of diet and exercise. Am J Physiol (Endocrinol Metab ), 236, E660-E666.
149. Kochan, R.G., Lamb, D.R., Reiman, E.M., & Schlender, K.K. (1981). Modified assays to detect activation of glycogen synthase following exercise. Am J Physiol (Endocrinol Metab ), 240, E197-E202.
150. Kolterman, O.G., Gray, R.S., Shapiro, G., Scarlett, J.A., Griffin, J., & Olefsky, J.M. (1984). The acute and chronic effects of sulfonylurea therapy in Type II diabetic subjects. Diabetes, 33, 346-354.
151. Kornfeld, R. & Brown, D.H. (1962). Preparation and properties of uridine diphosphate glucose-glycogen transglucosylase. Journal of Biological Chemistry, 237, 1772-1777.
152. Kruszynska, Y.T., Petranyi, G., Home, P.D., Taylor, R., & Alberti, K.G.M.M. (1986). Muscle enzyme activity and insulin sensitivity in type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 29, 699-705.
153. Laakso, M., Malkki, M., & Deeb, S.S. (1995). Amino acid substitutions in hexokinase II among patients with NIDDM. Diabetes, 44, 330-334.
154. Lager, I., Lönneroth, P., Von Schenck, H., & Smith, U. (1983). Reversal of insulin resistance in type 1 diabetes after treatment with continuous subcutaneous insulin infusion. British Medical Journal, 287, 1661-1664.
155. Laville, M., Auboeuf, D., Khalfallah, Y., Riou, J.P., & Vidal, H. (1996). Acute regulation by insulin of phosphatidylinositol-3-kinase, Rad, GLUT4, and lipoprotein lipase mRNA levels in human muscle. Journal of Clinical Investigation, 98, 43-49 (abstract).
156. Le Marchand-Brustel, Y., Gautier, N., Cormont, M., & Van Obberghen, E. (1995). Wortmannin inhibits the action of insulin but not that of okadaic acid inskeletal muscle: comparison with fatt cells. Endocrinology, 136, 3564-3570.
157. Lehto, M., Stoffel, M., Groop, L., Espinosa III, R., Le Beau, M.M., & Bell, G.I. (1993a). Assignment of the gene encoding glycogen synthase (GYS) to human chromosome 19, band q13.3. Genomics, 15, 460-461.
158. Lehto, M., Xiang, K., Stoffel, M., Espinosa III, R., Groop, L., Le Beau, M.M., & Bell, G.I. (1993b). Human hexokinase II: localization of the polymeric gene to chromosome 2. Diabetologia, 36, 1299-1302.
159. Lehto, M., Huang, X., Davis, E.M., Le Beau, M.M., Laurila, E., Eriksson,
160. Leloir, L.F., Olararria, J.M., Goldemberg, S.H., & Carminatti, H. (1959). Biosynthesis of glycogen from uridine diphosphate glucose. Archives of Biochemistry and Biophysics, 81, 508-520.
161. Lin, T., Kong, X., Haystead, T.A.J., Pause, A., Belsham, G., Sonenberg, N., & Lawrence, J.C. (1994). PHAS-I as a link between mitogen-activated protein kinase and translation initiation. Science, 266, 653-656.
162. Lin, T., Kong, X., Saltiel, A.R., Blackshear, P.J., & Lawrence, J.C. (1995). Control of PHAs-I by insulin in 3T3-L1 adipocytes. Journal of Biological Chemistry, 270, 18531-18538.
163. Lindell, T.J. & Stellwagen, E. (1968). Purification and properties of phosphofructokinase from yeast. Journal of Biological Chemistry, 243, 907-912.
164. Liou, R.-S. & Anderson, S. (1980). Activation of rabbit muscle phosphofructokinase by F-actin and reconstituted thin filaments. Biochemistry, 19, 2684-2688.
165. Lomako, J., Lomako, W.M., & Whelan, W.J. (1988). A self-glycisylating protein is the primer for rabbit muscle glycogen biosynthesis. FASEB J, 2, 3097-3103.
166. Lomako, J., Lomako, W.M., & Whelan, W.J. (1991). Proglycogen: a low-molecular-weight form of muscle glycogen. FEBS, 279, 223-228.
167. Löfman, M., Yki-Järvinen, H., Parkkonen, M., Lindström, J., Koranyi, L., Schalin-Jäntti, C., & Groop, L. (1995). Increased concentrations of glycogen synthase protein in skeletal muscle of patients with NIDDM. Am J Physiol (Endocrinol Metab), 269, E27-E32.
168. Lueck, J.D. & Fromm, H.J. (1974). Kinetics, mechanism, and regulation of rat skeletal muscle hexokinase. Journal of Biological Chemistry, 249, 1341-1347.
169. Lund, S., Holman, G.D., Schmitz, O., & Pedersen, O. (1993). GLUT4 content in the plasma membrane of rat skeletal muscle: comparative studies of the subcellular fractionation method and the exofacial photolabeling technique using ATB-BMPA. FEBS letters, 330, 312-318.
170. Luther, M.A. & Lee, J.C. (1986). The role of phosphorylation in the interaction of rabbit muscle phosphofructokinase with F-actin. Journal of Biological Chemistry, 261, 1753-1759.
171. Majer, M., Mott, D.M., Mochizuki, H., Rowles, J.C., Pedersen, O., Knowler, W.C., Bogardus, C., & Prochazaka, M. (1996). Association of glycogen synthase locus on 19q13 with NIDDM in Pima Indians. Diabetologia, 39, 314-321.
172. Manchester, J., Skurat, A.V., Roach, P., Hauschka, S.D., & Lawrence, J.C. (1996). Increased glycogen accumulation in transgenic mice overexpressing glycogen synthase in skeletal muscle. Proc Natl Acad Sci USA, 93, 10707-10711.
173. Mandarino, L.J. & Gerich, J.E. (1984). Prolonged sulfonyurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrapancreatic tissues. Diabetes Care, 7, 89-99.
174. Mandarino, L.J., Wright, K.S., Vertity, L.S., Nichols, J., Bell, J.M., Kolterman, O.G., & Beck-Nielsen, H. (1987). Effects of insulin infusion on human skeletal muscle pyruvat dehydrogenase,phosphofructokinase and glycogen synthase. Journal of Clinical Investigation, 80, 655-663.
175. Mandarino, L.J., Consoli, A., Kelley, D.E., Reilly, J.P., & Nurjhan, N. (1990). Fasting hyperglycemia normalizes oxidative and nonoxidative pathways of insulin-stimulated glucose metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab, 71, 1544-1551.
176. Mandarino, L.J., Printz, R.L., Cusi, K.A., Kinchington, P., O'Doherty, R.M., Osawa, H., Sewell, C., Consoli, A., Granner, D.K., & DeFronzo, R.A. (1995). Regulation of hexokinase II and glycogen synthase mRNA, protein, and activity in human muscle. Am J Physiol (Endocrinol Metab ), 269, E701-E708.
177. Mansour, T.E. & Mansour, J.M. (1962). Effects of serotonin (5-hydroxytryptamin) a.nd adenosine 3',5'-phospahet on phosphofructokinase from liver fluke fasciola hepatica. Journal of Biological Chemistry, 237, 629-634.
178. Marshall, S., Bacote, V., & Traxinger, R.R. (1991). Discovery of a metabolic pathway mediating glucose induced desensitization of the glucose transport system: role of hexosamine biosynthesis in the induction of insulin resistance. Journal of Biological Chemistry, 266, 4706-4712.
179. Matsutani, A., Janssen, R., Donis-Keller, H., & Permutt, M.A. (1992). A polymorphic (CA)n repeat element maps the human glucokinase gene (GCK) to chromosome 7p. Genomics, 12, 319-325.
180. McClain, D.A. & Crook, E.D. (1996). Hexosamines and insulin resistance. Diabetes, 45, 1003-1009.
181. McKnight, G.L., Mudri, S.L., Mathewes, S.L., Traxinger, R.R., Marshall, S., Sheppard, P.O., & O'Hara, P.J. (1992). Molecular cloning, cDNA sequence, and bacterial expression of human glutamine:fructose-6-phosphate amiod-transferase. Journal of Biological Chemistry, 267, 25208-25212.
182. Miele, C., Formisano, P., Condorelli, G., Caruso, M., Oriente, F., Andreozzi, F., Tocchetti, C.G., Riccardi, G., & Beguinot, F. (1997). Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects. Diabetologia, 40, 421-429.
183. Mikines, K.J., Sonne, B., Farrell, P.A., Tronier, B., & Galbo, H. (1989). Effect of training on the dose-response relationship for insulin action in men. J Appl Physiol, 66, 695-703.
184. Mocharla, H., Mocharla, R., & Hodes, M.E. (1990). Coupled reverse transcription-polymerase chain reaction (RT-PCR) as a sensitive and rapid method for isozyme genotyping. Gene, 93, 271-275.
185. Moller, D.E. & Flier, J.S. (1991). Insulin resistance - mechanisms, syndromes, and implications. N Engl J Med, 325, 938-948.
186. Moller, D.E. & O'Rahilly, S. (1993). Syndromes of severe insulin resistance: clinical and pathophysiological features. In D.E. Moller (Ed.). Insulin resistance (pp. 49-81 ). John Wiley & Sons: Chichester, New York, Brisbane, Toronto, Singapore.
187. Morgan, T.E., Cobb, L.A., Short, F.A., Ross, R. & Gunn, D.R. (1971). Effects of long-term exercise on human muscle mitochondria. In B. Pernow & B. Saltin (Eds.). Muscle metabolism during exercise (pp. 87-95). New York: Plenum
188. Munger, R., Temler, E., Jallut, D., Haesler, E., & Felber, J.-P. (1993). Correlations of glycogen synthase and phosphorylase activities with glycogen concentrations in human muscle biopsies. Evidence for a double-feedback mechanism regulating glycogen synthesis and breakdown. Metabolism, 42, 36-43.
189. Nakajima, H., Noguchi, T., Yamasaki, T., Kono, N., Tanaka, T., & Tarui, S. (1987). Cloning of human muscle phosphofructokinase cDNA. FEBS letters, 223, 113-116.
190. Nakajima, H., Kono, N., Ymasaki, T., Hamaguchi, T., Hotta, K., Kuwajima, M., Noguchi, T., Tanaka, T., & Tarui, S. (1990a). Tissue specificity in expression and alternative RNA splicing of human phosphofructokinase-M and L-genes. Biochemical and Biophysical Research Communications, 173, 1317-1321.
191. Nakajima, H., Yamasaki, T., Noguchi, T., Tanaka, T., Kono, N., & Tarui, S. (1990b). Evidence for alternative RNA splicing and possible alternative promoters in the human muscle phosphofructokinase gane at the 5' untranslated region. Biochemical and Biophysical Research Communications, 166, 637-641.
192. Nakajima, H., Hamaguchi, T., Yamasaki, T., & Tarui, S. (1995). Phosphofructokinase deficiency: recent advances in molecula biology. Muscle and Nerve, Supplement 3, S28-S34.
193. Nankervis, A., Proietto, J., Aitken, P., & Alford, F. (1984). Impaired insulin action in newly diagnosed type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 27, 497-503.
194. Nishi, S., Newman, M., & Bell, G.I. (1989). Hincll RFLP at the human hexokinase I (HKI) locus on chromosome 10. Nucleic Acids Research, 17, 7547
195. Nishi, S., Stoffel, M., Xiang, K., Shows, T.B., Bell, G.I., & Takeda, J. (1992). Human pancreatic beta-cell glucokinase: cDNA sequence and localization of the polymeric gene to chromosome 7, band p 13. Diabetologia, 35, 743-747.
196. Nuttall, F.Q., Gannon, M.C., Bai, G., & Lee, E.Y.C. (1994a). Primary structure of human liver glycogen synthase deduced by cDNA cloning. Archives of Biochemistry and Biophysics, 311, 443-449.
197. Nuttall, F.Q., Gannon, M.C., Kubic, V.L., & Hoyt, K.J. (1994b). The human liver glycogen synthase isoenzyme gene is located on the short arm of chromosome 12. Genomics, 19, 404-405.
198. Nyomba, B.L., Freymond, D., Raz, I., Stone, K., Mott, D.M., & Bogardus, C. (1990). Skeletal muscle glycogen synthase activity in subjects with non-insulin-dependent diabetes mellitus after glyburide therapy. Metabolism, 39, 1204-1210.
199. O'Brien, R.M. & Granner, D.K. (1991). Regulation of gene expression by insulin. Biochem J, 278, 609-619.
200. O'Brien, R.M. & Granner, D.K. (1996). Gene regulation. In D. LeRoith, S.I. Taylor & J.M. Olefsky (Eds.). Diabetes mellitus. A fundamental and clinical text (pp. 234-242). Philadelphia-New York: Lippincott-Raven.
201. O'Doherty, R.M., Bracy, D., Qsawa, H., Wasserman, D.H., & Granner, D.K. (1994). Rat muscle hexokinase II mRNA and activity are increased by a single bout of acute exercise. Am J Physiol (Endocrinol Metab ), 266, E171-E178.
202. Okubo, M., Bogardus, C., Lillioja, S., & Mott, D.M. (1988). Glucose-6-phosphate stimulation of human muscle glycogen synthase phosphatase. Metabolism, 37, 1171-1176.
203. Okubo, M., Villar-Palasi, C., Nagasaka, Y., Larner, J., Larner, A.C., Bai, G., & Lee, E.Y.C. (1991). Long-term effects of insulin on the enzyme activity and messenger RNA of glycogen synthase in rat hepatoma H4 cells: an effect of insulin on glycogen synthase mRNA stability. Archives of Biochemistry and Biophysics, 288, 126-130.
204. Olefsky, J.M. & Kolterman, O.G. (1981). Mechanisms of insulin resistance in obesity and non-insulin-dependent (type II) diabetes. The American Journal of Medicine, 70, 151-168.
205. Orho, M., Nikula-Ijäs, P., Schalin-Jäntti, C., Permutt, M.A., & Groop, L. (1995). Isolation and characterization of the human muscle glycogen synthase gene. Diabetes, 44, 1099-1105.
206. Ortmeyer, H.K., Bodkin, N.L., & Hansen, B.C. (1994). Relationship of skeletal muscle glucose 6-phosphate to glucose disposal rate and glycogen synthase activity in insulin-resistant and non-insulin-dependent diabetic rhesus monkeys. Diabetologia, 37, 127-133.
207. Parker, P.J., Caudwell, F.B., & Cohen, P. (1983). Glycogen synthase from rabbit skeletal muscle; Effect of insulin on the state of phosphorylation on the seven phosphoserine residues in vivo. European Journal of Biochemistry, 130, 227-234.
208. Parra, J. & Pette, D. (1995). Effects of low-frequency stimulation on soluble and structure-bound activities of hexokinase and phosphofructokinase in rat fast-twitch muscle. Biochimica et Biophysica Acta, 1251, 154-160.
209. Passonneau, J.V. & Lowry, O.H. (1962). Phosphofructokinase and the pasteur effect.Biochemical and Biophysical Research Communications, 7, 10-15.
210. Passonneau, J.V. & Lowry, O.H. (1963). P-fructokinase and the control of the citric acid cycle. Biochemical and Biophysical Research Communications, 13, 372-379.
211. Pause, A., Belsham, G.J., Gingras, A., DonzJ, O., Lin, T., Lawrence, J.C., & Sonenberg, N. (1994). Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function. Nature, 371, 762-767.
212. Pedersen, O. & Beck-Nielsen, H. (1987). Insulin resistance and insulin-dependent diabetes mellitus. Diabetes Care, 10, 516-523.
213. Pedersen, O. (1993). Glucose transporters and diabetes mellitus. In S.M. Marshall, P.D. Home, K.G.M.M. Alberti & L.P. Krall (Eds.), (pp. 30-54).
214. Pendergrass, M., Gulli, G., Saccomani, M.P., Cobelli, C., & DeFronzo, R.A. (1994). In vivo glucose transport and phosphorylation in skeletal muscle is impaired in obese and diabetic patients. Diabetes, 43, 72A (abstract).
215. Permeggiani, A. & Bowman, R.H. (1963). Regulation of phosphofructokinase activity by citrate in normal and diabetic muscle. Biochemical and Biophysical Research Communications, 12, 268-273.
216. Perseghin, G., Price, T.B., Petersen, K.F., Roden, M., Cline, G. W., Gerow, K., Rothman, D.L., & Shulman, G.I. (1996). Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med, 335, 1357-1362.
217. Picano, E., Lattanzi, F., Masini, M., Distante, A., & L'abbate, A. (1987). Usefulness of a high-dose dipyridamole-echocardiography test for diagnosis of syndrome X. Am J Cardiol, 60, 508-512.
218. Picton, C., Aitken, A., Bilham, T., & Cohen, P. (1982). Multisite phosphorylation of glycogen synthase from rabbit skeletal muscle. European Journal of Biochemistry, 124, 37-45.
219. Piehl, K., Adolfsson, S., & Nazar, K. (1974). Glycogen storage and glycogen synthase activity in trained and untrained muscle of man. Acta Physiol Scand, 90, 779-788.
220. Piras, R., Rothman, L.B., & Cabib, E. (1968). Regulation of muscle glycogen synthase by metabolites. Differential effects of the 1 and D forms. Biochemistry, 7, 56-66.
221. Piras, R. & Staneloni, R. (1969). In vivo regulation of rat muscle glycogen synthase activity. Biochemistry, 8, 2153-2160.
222. Pitcher, J., Smythe, C., Campbell, D.G., & Cohen, P. (1987). Identification of the 38-kDa subunit of rabbit skeletal muscle glycogen synthase as glycogenin. European Journal of Biochemistry, 169, 497-502.
223. Pollare, T., Lithell, H., & Berne, C. (1989a). A comparison of the effects of hydrchlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med, 321, 868-873.
224. Pollare, T., Lithell, H., Selinus, I., & Berne, C. (1989b). Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. British Medical Journal, 298, 1152-1157.
225. Postic, C., Leturque, A., Rencurel, F., Printz, R.L., Forest, C., Granner, D.K., & Girard, J. (1993). The effects of hyperinsulinemia and hyperglycemia on GLUT4 and hexokinase II mRNA and protein in rat skeletal muscle and adipose tissue. Diabetes, 42, 922-929.
226. Prager, R., Schernthaner, G., & Graf, H. (1985). Effect of metformin on peripheral insulin sensitivity in non-insulin dependent diabetes mellitus. Diabetes/Metabolism Reviews, 11, 346-350.
227. Printen, J.A., Brady, M.J., & Saltiel, A.R. (1997). PTG, a protein phosphatase 1-binding protein with a role in glycogen metabolism. Science, 275, 1475-1478.
228. Printz, R.L., Koch, S., Potter, L.R., OlDoherty, R.M., Tiesinga, J.J., Moritz, S., & Granner, D.K. (1993a). Hexokinase II mRNA and gene structure, regulation by insulin, and evolution. Journal of Biological Chemistry, 268, 5209-5219.
229. Printz, R.L., Magnuson, M.A., & Granner, D.K. (1993b). Mammalian glucokinase. Annu Rev Nutr, 13, 463-496.
230. Printz, R.L., Ardehali, H., Koch, S., & Granner, D.K. (1995). Human hexokinase II mRNA and gene structure. Diabetes, 44, 290-294.
231. Randin, J.-P., Scazziga, B., Jequier, E., & Felber, J.P. (1985). Study of glucose and lipid metabolism by continous indirect calorimetry in Graves' disease: Effect of an oral glucose load. J Clin Endocrinol Metab, 61, 1165-1171.
232. Randle, P.J., Garland, P.B., Hales, C.N., & Newsholme, E.A. (1963). The glucose fatty-acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet, 1, 785-789.
233. Raz, I., Katz, A., & Spencer, M.K. (1991). Epinephrine inhibits insulin-mediated glycogenesis but enhances glycolysis in human skeletal muscle. Am J Physiol (Endocrinol Metab ), 760, E430-E435.
234. Reaven, G.M. (1995). The fourth Musketeer-from Alexandre Dumas to Claude Bernard. Diabetologia, 38, 3-13.
235. Regen, D.M., Davis, W.W., Morgan, H.E., & Park, C.R. (1964). The regulation of hexokinase and phosphofructokinase activity in heart muscle. Journal of Biological Chemistry, 239, 43-49.
236. Reid, S. & Masters, C. (1985). On the developmental properties and tissue interactions of hexokinase. Mechanisms of Aging and Development, 31, 197-212.
237. Roach, P.J. & Larner, J. (1976a). Rabbit skeletal muscle glycogen synthase. Enzyme phosphorylation state and effector concentrations as interacting control parameters.Journal of Biological Chemistry, 251, 1920-1925.
238. Roach, P.J., Takeda, Y., & Larner, J. (1976b). Rabbit skeletal muscle glycogen synthase. Relationship between phosphorylation state and kinetic properties. Journal of Biological Chemistry, 251, 1913-1919.
239. Roach, P.J. (1990). Control of glycogen synthase by hierarchal protein phosphorylation. FASEB J, 4, 2961-2968.
240. Roberts, S.J. & Somero, G.N. (1987). Binding of phosphofructokinase to filamentous actin. Biochemistry, 26, 3437-3442.
241. Robinson, K.A., Sens, D.A., & Buse, M.G. (1993). Pre-exposure to glucosamine induces insulin resistance of glucose transport and glycogen synthase in isolated rat skeletal muscles: study of mechanisms in muscle and rat-1-fibroblast overexpressing the human insulin receptor. Diabetes, 42, 1333-1346.
242. Roden, M., Price, T.B., Perseghin, G., Petersen, K.F., Rothman, D.L., Cline, G. W., & Shulman, G.I. (1996). Mechanism of free fatty acid-induced insulin resistance in humans. Journal of Clinical Investigation, 97, 2859-2865.
243. Rodnick, K.J., Haskell, W.L., Swislocki, A.L.M., Foley, J.E., & Reaven, G.M. (1987). Improved insulin action in muscle, liver, and adipose tissue in physically trained humans. Am J Physiol (Endocrinol Metab ), 253, E489-E495.
244. Rodriquez, I.R. & Whelan, W.J. (1985). A novel glycosyl-amino acid linkage: rabbi-muscle glycogen is covalently linked to a protein via tyrosine. Biochemical and Biophysical Research Communications, 132, 829-836.
245. Rogers, P.A., Fisher, R.A., & Harris, H. (1975). An electrophoretic study of the distribution and properties of human hexokinases. Biochemical Genetics, 13, 857-866.
246. Rosell-Perez, M. & Larner, J. (1964). Studies on UDPG: a-1,4-glucan a-4-glucosyltransferase. VI. Specificity and structural requirments for the activator of the D form of the dog muscle enzyme. Biochemistry, 3, 773-780.
247. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation, 89, 1069-1075.
248. Rothman, D.L., Magnusson, I., Cline, G., Gerard, D., Kahn, C.R., Shulman, R.G., & Shulman, G.I. (1995). Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA, 92, 983-987.
249. Sakaue, H., Hara, K., Noguchi, T., Matozaki, T., Kotani, K., Ogawa, W., Yonezawa, K., Waterfield, M.D., & Kasuga, M. (1995). Ras-independent and wortmannin-sensitive activation of glycogen synthase by insulin in chines hamster ovary cells. Journal of Biological Chemistry, 270, 11304-11309.
250. Saltin, B., Lindegärde, F., Houston, M., H̀rlin, R., Nygaard, E., & Gad, P. (1979). Physical training and glucose tolerance in middle-aged men with chemical diabetes. Diabetes, 28, suppl. 1, 30-32.
251. Sato, Y., Iguchi, A., & Sakamoto, N. (1984). Biochemical determination of training effects using insulin clamp technique. Hormone and metabolic re-search, 16, 483-486.
252. Schalin, C., Heikkinen, S., Härkönen, M., & Groop, L. (1990). Activation of muscle glycogen synthase (GS) and phosphofructokinase (PFK.) by insulin in firstdegree relatives of patients with NIDDM. Diabetes, 39, suppl. 2, 341A, abstract.
253. Schalin-Jäntti, C., Härkönen, M., & Groop, L. (1992). Impaired activation of glycogen synthase in people at increased risk for developing NIDDM. Diabetes, 41, 598-604.
254. Scheen, A.J., Paquot, N., Castillo, M.J., & Lefèbvre, P.J. (1994). How to measure insulin action in vivo. Diabetes/Metabolism Reviews, 10, 151-188.
255. Sharma, P.M., Reddy, G.R., Vora, S., Babior, B.M., & McLachlan, A. (1989). Cloning and expression of a human muscle phosphofructokinase cDNA. Gene, 77, 177-183.
256. Sharma, P.M., Reddy, G.R., Babior, B.M., & McLachlan, A. (1990). Alternative splicing of the transcript encoding the human muscle isoenzyme of phosphofructokinase. Journal of Biological Chemistry, 265, 9006-9010.
257. Shen, D.-C., Shieh, S.-M., Fuh, M.M.-T., Wu, D.-A., Chen, Y.-D.I., & Reaven, G.M. (1988). Resistance to insulin-stimulated glucose uptake in patients with hypertension. J Clin Endocrinol Metab, 66, 580-583.
258. Shen, S., Reaven, G.M., & Fabquhar, J. W. (1970). Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. Journal of Clinical Investigation, 49, 2151-2160.
259. Sheorain, V.S., Ramakrishna, S., Benjamin, W.B., & Soderling, T.R. (1985). Phosphorylation of sites 3 and 2 in rabbit skeletal muscle glycogen synthase by multifunctional protein kinase (ATP-citrate lyase kinase). Journal of Biological Chemistry, 260, 12287-12292.
260. Shulman, G.I. (1994). PL-4: New insights into the pathogenesis of type II diabetes mellitus with NMR. Eur J Endocrinol, 130. Suppl 2, 7-8.
261. Sigel, P. & Pette, D. (1969). Intracellular localization of glycogenolytic and glycolytic enzymes in white and red rabbit skeletal muscel. Journal of Histochemistry and Cytochemistry, 17, 225-237.
262. Skarfos, E.T., Eithell, H.O., Selinus, I., & Åberg, H. (1989). Do antihypertensive drugs prcipitate diabetes in predisposed men? British Medical Journal, 298, 1147-1152.
263. Smythe, C., Watt, P., & Cohen, P. (1990). Further studies on the role of glycogenin in glycogen biosynthesis. European Journal of Biochemistry, 189, 199-204.
264. Smythe, C. & Cohen, P. (1991). The discovery of glycogenin and the priming mechanism for glycogen biogenesis. European Journal of Biochemistry, 200, 625-631.
265. Sochor, M., Baquer, N.Z., Hothersall, J.S., & McLean, P. (1990). Effect of experimental diabetes on the activity of hexokinase isoenzyms in tissues of the rat. Biochemistry International, 22, 467-474.
266. Stalmans, W., Bollen, M., & Mvumbi, L. (1987). Control of glycogen synthesis in health and disease. Diabetes/Metabolism Reviews, 3, 127-161.
267. Strålfors, P., Hiraga, A., & Cohen, P. (1985). The protein phosphatases involved in cellular regulation Purification and characterisation of the glycogen-bound form of protein phosphatase-1 from rabbit skeletal muscle. European Journal of Biochemistry, 149, 295-303.
268. Sutherland, C., Leighton, I.A., & Cohen, P. (1993). Inactivation of glycogen synthase kinase-3β by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J, 296, 15-19.
269. Taylor, A.W., Thayer, R., & Rao, S. (1971). Human skeletal muscle glycogen synthetase activities with exercise and training. Can J Physiol Pharmacol, 50, 411-415.
270. Taylor, R.W., Printz, R.L., Armstrong, M., Granner, D.K., Alberti, K.G.M.M., Turnbull, D.M., & Walker, M. (1996). Variant sequences of the hexokinase II gene in familial NIDDM. Diabetologia, 39, 322-328.
271. Thiebaud, D., DeFronzo, R.A., Jacot, E., Golay, A., Acheson, K., Maeder, E., Jequier, E., & Felber, J.P. (1982a). Effect of long chain triglyceride infusion on glucose metabolism in man. Metab Clin Exp, 31, 1128-1136.
272. Thiebaud, D., Jacot, E., DeFronzo, R.A., Maeder, E., Jequier, E., & Felber, J.P. (1982b). The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man. Diabetes, 31, 957-963.
273. Thomas, J.A., Schleuder, K.K., & Larner, J. (1968). A rapid filter paper assay for UDP glucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose. Analytical biochemistry, 25, 486-499.
274. Thompson, D.B., De Gregorio, M., & Sommercorn, J. (1996). Insulin regulation of multiple ribonucleic acid species in human skeletal muscle in insulin-sensitive and insulin-resistant subjects. J Clin Endocrinol Metab, 81, 519-523.
275. Thorburn, A. W., Gumbiner, B., Bulacan, F., Wallace, P., & Henry, R.R. (1990). Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. Journal of Clinical Investigation, 85, 522-624.
276. Thorburn, A.W., Gumbiner, B., Bulacan, F., Brechtel, G., & Henry, R.R. (1991). Multiple defects in muscle glycogen synthase activity contributes to reduced glycogen synthesis in non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation, 87, 489-495.
277. Traxinger, R.R. & Marshall, S. (1991). Coordinated regulation of glutamine: fructose-6-phosphate amidotransferase activity by insulin, glucose, and glutamine. Journal of Biological Chemistry, 266, 10148-10154.
278. Trivedi, B. & Danforth, W.H. (1966). Effect of pH on the kinetics of frog muscle phosphofructokinase. Journal of Biological Chemistry, 241, 4110-4114.
279. Uyeda, K. (1979). Phosphofructokinase. In A. Meister (Ed.). Advances in enzymology and related areas of molecular biology. Vol 48 (pp. 193-244). John Wiley & Sons: New York, Chichester, Brisbane, Toronto
280. Vaag, A., Skøtt, P., Damsbo, P., Gall, M.-A., Richter, E.A., & Beck-Nielsen, H. (1991). Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation, 88, 1282-1290.
281. Vaag, A., Damsbo, P., Hother-Nielsen, O., & Beck-Nielsen, H. (1992a). Hyperglycemia compensates for the defect in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia, 35, 80-88.
282. Vaag, A., Henriksen, J.E., & Beck-Nielsen, H. (1992b). Decreased insulin activation of glycogen synthase in skeletal muscles in young non-obese caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation, 89, 782-788.
283. Vaag, A., Handberg, A., Skøtt, P., Richter, E.A., & Beck-Nielsen, H. (1994). Glucose-fatty acid cycle operates inhumans at the levels of both whole body and skeletal muscel during low and high physiological plasma insulin concentrations. European Journal of Endocrinology, 130, 70-79.
284. Vaulont, S., Munnich, A., Decaux, J., & Kahn, A. (1986). Transcriptional and post-transcriptional regulation of L-type pyruvate kinase gene expression in rat liver. Journal of Biological Chemistry, 261, 7621-7625.
285. Vestergaard, H., Bjørbæk, C., Andersen, P.H., Bak, J.F., & Pedersen, O. (1991). Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients. Diabetes, 40, 1740-1745.
286. Vestergaard, H., Lund, S., Larsen, F.S., Bjerrum, O.J., & Pedersen, O. (1993). Glycogen synthase and phosphofructokinase protein and mRNA levels in skeletal muscle from insulin resistant patients with non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation, 91, 2342-2350.
287. Vestergaard, H., Andersen, P.H., Lund, S., Schmitz, O., Junker, S., & Pedersen. O. (1994a). Pre- and posttranslational upregulation of muscle-specific glycogen synthase in athletes. Am J Physiol (Endocrinol Metab), 266, E92-E101.
288. Vestergaard, H., Andersen, P.H., Lund, S., Vedel, P., & Pedersen, O. (1994b). Expression of glycogen synthase and phosphofructokinase in muscle from Type 1 (insulin-dependent) diabetic patients before and after intensive insulin treatment. Diabetologia, 37, 82-90.
289. Vestergaard, H., Vorwerk, P., Bjørbæk, C., De Meyts, P., & Pedersen, O. (1994c). Congenital muscle fibre type disproportion myopathy characterized by insulin resistant diabetes and mutations in insulin receptor and insulin receptor substrate-1 genes. Diabetes, 43, 145A, no.453
290. Vestergaard, H., Bjørbæk, C., Hansen, T., Larsen, F.S., Granner, D.K., & Pedersen, O. (1995;a). Impaired activity and gene expression of hexokinase II in muscle from NIDDM patients. Journal of Clinical Investigation, 96, 2639-2645.
291. Vestergaard, H., Klein, H.H., Hansen, T., Müller, J., Skovby, F., Bjørbæk, C., Røder, M.E., & Pedersen, O. (1995b). Severe insulin-resistant diabetes mellitus in patients with congenital muscle fiber type disproportion myopathy. Journal of Clinical Investigation, 95, 1925-1932.
292. Vestergaard, H., Lund. S., Bjørbæk, C., & Pedersen, O. (1995c). Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylurea-induced improvement of glycaemic control. Diabetologia, 38, 1230-1238.
293. Vestergaard, H., Skøtt, P., Steffensen, R., Wroblewski, H., Pedersen, O., & Kastrup, J. (1995d). Insulin-resistant glucose metabolism in patients with microvascular angina-syndrome X. Metabolism, 44, 876-882.
294. 142->His substitution. Diabetes, 44, 340-346.
295. Vora, S., Seaman, C., Durham, S., & Piomelli, S. (1980). Isoenzymes of human phosphofructokinase: Identification and subunit structural characterization of a new system. Proc Natl Acad Sci USA, 77, 62-66.
296. Vora, S. & Francke, U. (1981). Assignment of the human gene for liver-type 6-phosphofructokinase isoenzyme (PFKL) to chromosome 21 by using somatic cell hybrids and monoclonal anti-L antibody. Proc Natl Acad Sci USA, 78, 3738-3742.
297. Vora, S., Durham, S., Martinville, B., George, D.L., & Francke, U. (1982). Assignment of the human gene for muscle type phosphofructokinase (PFKM) to chromosomes 1 (region cen-q32) using somatic cell hybrids and monoclonal anti-M antibody. Somat Cell genet, 8, 95-104.
298. Vora, S. (1983). Isozymes of human phosphofructokinase: Biochemical and genetic aspects.Current Topics in Biological and Medical Research, 11, 3-23.
299. Vorwerk, P., Vestergaard, H., Christoffersen, C.T., De Meyts, P., & Pedersen, O. (1994). Insulin receptor mutations in a novel syndrome of insulin resistance. Diabetologia, 37 Suppl 1, A29 (abstract).
300. Vuorinen-Markkola, H., Koivisto, V.A., & Yki-Järvinen, H. (1992). Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type 1 diabetic patients. Diabetes, 41, 571-580.
301. Walker, M., Fulcher, G.R., Sum, C.F., Ørskov, H., & Alberti, K.G.M.M. (1991). Effect of glycemia and nonesterified fatty acids on forearm glucose uptake in normal humans. Am J Physiol (Endocrinol Metab ), 261, E304-E311.
302. Wallberg-Henriksson, H., Gunnarsson, R., DeFronzo, R.A., Felig, P., Östman, J., & Wahren, J. (1982). Increased peripheral insulin sensitivity and muscle mitochondrial enzymes but unchanged blood glucose control in type I diabetics after physical training. Diabetes, 31, 1044-1050.
303. Wang, A.M., Doyle, M.V., & Mark, D.F. (1989). Quantitation of mRNA by polymerase chain reaction. Proc Natl Acad Sci USA, 86, 9717-9721.
304. Wang, Y. & Roach, P.J. (1993). Inactivation of rabbit muscle glycogen synthase by glycogen synthase kinase-3. Journal of Biological Chemistry, 268, 23876-23880.
305. Weil, D., Cottreau, D., & van Cong, N. (1980). Assignment of the gene for P-type phosphofructokinase to human chromosome 10 by somatic cell hybridization and specific immunoprecipitation. Ann Hum Genet, 44, 11-16.
306. Wells, A.M., Sutcliffe, I.C., Johnson, A.B., & Taylor, R. (1993). Abnormal activation of glycogen synthesis in fibroblasts from NIDDM subjects. Diabetes, 42, 583-589.
307. Wilson, J.E. (1985). Regulation of mammalian hexokinase activity. In R. Beitner (Ed.). Regulation of carbohydrate metabolism (pp. 45-85). CRC, Boca Raton
308. Wilson, J.E. (1994). Hexokinases. Rev Physiol Biochem Pharmacol, 126, 65-198.
309. Wright, K.S., Beck-Nielsen, H., Kolterman, O.G., & Mandarino, L.J. (1988). Decreased activation of skeletal muscle glycogen synthase by mixed-meal ingestion in NIDDM. Diabetes, 37, 436-440.
310. Yamasaki, T., Nakajima, H., Kono, N., Hotta, K., Yamada, K., Imai, E., Kuwajima, M., Noguchi, T., Tanaka, T., & Tarui, S. (1991). Structure of the entire human muscle phosphofructokinase-encoding gene: a two promoter system. Gene, 104, 277-282.
311. Yki-Järvinen, H. & Koivisto, V.A. (1983). Effects of body composition on insulin sensitivity. Diabetes, 32, 965-969.
312. Yki-Järvinen, H. & Koivisto, V.A. (1986). Natural course of insulin resistance in type 1 diabetes. N Engl J Med, 315, 224-230.
313. Yki-Järvinen, H., Mott, D.M., Young, A.A., Stone, K., & Bogardus, C. (1987). Regulation of glycogen synthase and phosphorylase activities by glucose and insulin in human skeletal muscle. Journal of Clinical Investigation, 80, 95-100.
314. Yki-Järvinen, H., Sahlin, K., Ren, J.M., & Koivisto, V.A. (1990). Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type I diabetic patients. Diabetes, 39, 157-167.
315. Yki-Järvinen, H., Puhakainen, I., & Koivisto, V.A. (1991). Effect of free fatty acids on glucose uptake and nonoxidative glycolysis across human fore-arm in the basal state and during insulin stimulation. J Clin Endocrinol Metab, 72, 1268-1277.
316. Yki-Järvinen, H. (1992). Glucose toxicity.Endocrine Reviews, 13, 415-431.
317. Yki-Järvinen, H., Daniels, M.C., Virkamäki, A., Mäkimattila, S., DeFronzo, R.A., & McClain, D. (1996). Increased glutamine: fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM. Diabetes, 45, 302-307.
318. Zenobi, P.D., Graf, S., Ursprung, H., & Froesch, E.R. (1992). Effects of insulin-like growth factor-1 on glucose tolerance, insulin levels, and insulin secretion. Journal of Clinical Investigation, 89, 1908-1913.
319. Zhang, W., Browner, M.F., Fletterick, R.J., DePaoli-Roach, A.A., & Roach, P.J. (1989). Primary structure of rabbit skeletal muscle glycogen synthase deduced from cDNA clones. FASEB J, 3, 2532-2536.
320. Zhang, Y., Wat, N., Stratton, I.M., Warren-Perry, M.G., Orho, M., Groop, L., & Turner, R.C. (1996). UKPDS 19: Heterogeneity in NIDDM: separate contributions of IRS-1 and β3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase mutations. Diabetologia, 39, 1505-1511.
321. Zouali, H., Velho, G., & Froguel, P. (1993). Polymorphisms of glycogen synthase gene and non-insulin-dependent diabetes mellitus. Letter to the Editor. N Engl J Med, 328, 1568.